Literature DB >> 12481018

Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.

Zhi Rong Qian1, Chiun Chei Li, Hiroyuki Yamasaki, Noriko Mizusawa, Katsuhiko Yoshimoto, Shozo Yamada, Takashi Tashiro, Hidehisa Horiguchi, Shingo Wakatsuki, Mitsuyoshi Hirokawa, Toshiaki Sano.   

Abstract

E-cadherin/catenin complex regulates cellular adhesion and motility and is believed to function as an invasion suppressor system. In a number of cancers, abnormal and reduced expression of E-cadherin/catenin complex is associated with tumor invasion and metastasis. Prolactinomas show frequent invasion on the surrounding structures, despite their histologically benign nature. Furthermore, gender-based differences in endocrine and surgical findings are found in patients with prolactinoma. To understand biological factors governing prolactinoma behavior, this study analyzed the expression of E-cadherin; alpha-, beta-, and gamma-catenins; p120; and cell proliferation marker MIB-1 labeling index in 13 invasive tumors (9 in men, 4 in women), 26 noninvasive tumors (4 in men, 22 in women), and 8 normal anterior pituitaries by immunohistochemistry. Immunostaining of E-cadherin; alpha-, beta-, and gamma-catenins; and p120 showed a membranous pattern of reactivity and generally stronger in normal pituitaries than in prolactinomas. Expression of E-cadherin and beta-catenin was significantly lower in invasive than in noninvasive prolactinomas (P <.002 and P <.005, respectively), and reduced expression of E-cadherin and beta-catenin was more frequent in invasive than in noninvasive prolactinomas (P <.001 and P <.05, respectively); in contrast, gamma-catenin expression showed higher in invasive than in noninvasive prolactinomas (P <.05). Expression of E-cadherin was significantly lower in macroprolactinomas than in microprolactinomas (P <.01), and decreased expression of E-cadherin and beta-catenin predicted high MIB-1 expression (P <.05). Moreover, the expression of E-cadherin and beta-catenin was significantly lower in macroprolactinomas in men than in those in women (P <.01 and P <.02, respectively). No statistical correlations were observed between expression of alpha-catenin, p120, and clinicopathologic features. In conclusion, the reduction of E-cadherin and beta-catenin expression was related to invasiveness and proliferative status of prolactinomas and correlated with the more aggressive behavior of prolactinomas in men compared with in women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481018     DOI: 10.1097/01.MP.0000039572.75188.1A

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  22 in total

1.  N-cadherin loss in POMC-expressing cells leads to pituitary disorganization.

Authors:  Ashley D Himes; Rachel M Fiddler; Lori T Raetzman
Journal:  Mol Endocrinol       Date:  2011-01-27

Review 2.  Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.

Authors:  Tomáš Česák; Pavel Poczos; Jaroslav Adamkov; Jiří Náhlovský; Petra Kašparová; Filip Gabalec; Petr Čelakovský; Ondrej Choutka
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

Review 3.  The molecular pathogenetic role of cell adhesion in endocrine neoplasia.

Authors:  S Ezzat; S L Asa
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 4.  Genetics and proteomics of pituitary tumors.

Authors:  Sylvia L Asa; Shereen Ezzat
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

5.  Beta-catenin mutations in craniopharyngiomas and pituitary adenomas.

Authors:  Eftychia Oikonomou; Diele C Barreto; Beatriz Soares; Luiz De Marco; Michael Buchfelder; Eric F Adams
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

6.  Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas.

Authors:  Elaine Lu Wang; Zhi Rong Qian; Shozo Yamada; Md Mustafizur Rahman; Naoko Inosita; Teruyoshi Kageji; Hideko Endo; Eiji Kudo; Toshiaki Sano
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

7.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.

Authors:  Yasushi Tanaka; Toshiaki Sano; Zhi Rong Qian; Mitsuyoshi Hirokawa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

8.  Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours.

Authors:  J Alami; B R Williams; H Yeger
Journal:  Mol Pathol       Date:  2003-08

Review 9.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

Review 10.  Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.

Authors:  Maria Gueorguiev; Ashley B Grossman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.